NOTA-Octreotide

NOTA-Octreotide trifluoroacetate is a somatostatin analogue optimized for stable complexation with aluminum-[18F] fluoride in a rapid one-pot radiolabeling process.
This somatostatin analog targets somatostatin receptor subtype 2 (SSTR2) overexpressed in neuroendocrine tumors, providing high tumor uptake, low background, and excellent
PET/CT image contrast for precise diagnosis, staging, and therapy planning.
Ensure consistent radiochemical yield with our strictly controlled, industry-essential compounds. Select your required grade (GMP/Research) and quantity to receive a personalized proposal from our team.